Breast Cancer Liquid Biopsy Testing Devices Market Size, Trends, Analysis, and Outlook By Type (CTCs , Circulating Nucleic Acids, Extracellular Vesicles), by Region, Country, Segment, and Companies, 2024-2030
The global Breast Cancer Liquid Biopsy Testing Devices market size is poised to register 19.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Breast Cancer Liquid Biopsy Testing Devices market By Type (CTCs , Circulating Nucleic Acids, Extracellular Vesicles).
The future of breast cancer liquid biopsy testing devices is marked by innovations in circulating tumor cell (CTC) isolation, cell-free DNA (cfDNA) analysis, and exosome profiling to enable non-invasive monitoring of disease progression, treatment response, and minimal residual disease detection in breast cancer patients. Key trends include the development of microfluidic-based platforms and lab-on-a-chip technologies for efficient CTC capture and enumeration from peripheral blood samples, allowing for early detection of metastatic spread and treatment monitoring. Additionally, the integration of next-generation sequencing and digital PCR techniques enables sensitive detection of tumor-specific mutations and copy number variations in cfDNA, providing insights into tumor heterogeneity and clonal evolution. Moreover, the characterization of exosomal cargo, including microRNAs, proteins, and metabolites, offers potential biomarkers for predicting treatment response and identifying therapeutic targets in breast cancer. Furthermore, the customization of liquid biopsy assays to match patient-specific tumor profiles and treatment regimens drives personalized medicine approaches and improves clinical decision-making in breast cancer management..
Breast Cancer Liquid Biopsy Testing Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Breast Cancer Liquid Biopsy Testing Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Breast Cancer Liquid Biopsy Testing Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Breast Cancer Liquid Biopsy Testing Devices industry.
Key market trends defining the global Breast Cancer Liquid Biopsy Testing Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Breast Cancer Liquid Biopsy Testing Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Breast Cancer Liquid Biopsy Testing Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Breast Cancer Liquid Biopsy Testing Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Breast Cancer Liquid Biopsy Testing Devices industry
Leading Breast Cancer Liquid Biopsy Testing Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Breast Cancer Liquid Biopsy Testing Devices companies.
Breast Cancer Liquid Biopsy Testing Devices Market Study- Strategic Analysis Review
The Breast Cancer Liquid Biopsy Testing Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Breast Cancer Liquid Biopsy Testing Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Breast Cancer Liquid Biopsy Testing Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Breast Cancer Liquid Biopsy Testing Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Breast Cancer Liquid Biopsy Testing Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Breast Cancer Liquid Biopsy Testing Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Breast Cancer Liquid Biopsy Testing Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Breast Cancer Liquid Biopsy Testing Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Breast Cancer Liquid Biopsy Testing Devices in Asia Pacific. In particular, China, India, and South East Asian Breast Cancer Liquid Biopsy Testing Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Breast Cancer Liquid Biopsy Testing Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Breast Cancer Liquid Biopsy Testing Devices.
Breast Cancer Liquid Biopsy Testing Devices Market Company Profiles
The global Breast Cancer Liquid Biopsy Testing Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are A. Menarini Industrie Farmaceutiche Riunite Srl, Agena Bioscience Inc, Bio Rad Laboratories Inc, Exact Sciences Corp, F. Hoffmann La Roche Ltd, Fluxion Biosciences Inc, Guardant Health Inc, Illumina Inc, Isogen Life Science BV, Myriad Genetics Inc, Natera Inc, NeoGenomics Laboratories Inc, Novogene Corp, OncoDNA SA, Pfizer Inc, QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp, Thermo Fisher Scientific Inc.
Recent Breast Cancer Liquid Biopsy Testing Devices Market Developments
The global Breast Cancer Liquid Biopsy Testing Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Breast Cancer Liquid Biopsy Testing Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
A. Menarini Industrie Farmaceutiche Riunite Srl
Agena Bioscience Inc
Bio Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann La Roche Ltd
Fluxion Biosciences Inc
Guardant Health Inc
Illumina Inc
Isogen Life Science BV
Myriad Genetics Inc
Natera Inc
NeoGenomics Laboratories Inc
Novogene Corp
OncoDNA SA
Pfizer Inc
QIAGEN NV
SAGA Diagnostics AB
Sysmex Corp
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The future of breast cancer liquid biopsy testing devices is marked by innovations in circulating tumor cell (CTC) isolation, cell-free DNA (cfDNA) analysis, and exosome profiling to enable non-invasive monitoring of disease progression, treatment response, and minimal residual disease detection in breast cancer patients. Key trends include the development of microfluidic-based platforms and lab-on-a-chip technologies for efficient CTC capture and enumeration from peripheral blood samples, allowing for early detection of metastatic spread and treatment monitoring. Additionally, the integration of next-generation sequencing and digital PCR techniques enables sensitive detection of tumor-specific mutations and copy number variations in cfDNA, providing insights into tumor heterogeneity and clonal evolution. Moreover, the characterization of exosomal cargo, including microRNAs, proteins, and metabolites, offers potential biomarkers for predicting treatment response and identifying therapeutic targets in breast cancer. Furthermore, the customization of liquid biopsy assays to match patient-specific tumor profiles and treatment regimens drives personalized medicine approaches and improves clinical decision-making in breast cancer management..
Breast Cancer Liquid Biopsy Testing Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Breast Cancer Liquid Biopsy Testing Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Breast Cancer Liquid Biopsy Testing Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Breast Cancer Liquid Biopsy Testing Devices industry.
Key market trends defining the global Breast Cancer Liquid Biopsy Testing Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Breast Cancer Liquid Biopsy Testing Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Breast Cancer Liquid Biopsy Testing Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Breast Cancer Liquid Biopsy Testing Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Breast Cancer Liquid Biopsy Testing Devices industry
Leading Breast Cancer Liquid Biopsy Testing Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Breast Cancer Liquid Biopsy Testing Devices companies.
Breast Cancer Liquid Biopsy Testing Devices Market Study- Strategic Analysis Review
The Breast Cancer Liquid Biopsy Testing Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Breast Cancer Liquid Biopsy Testing Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Breast Cancer Liquid Biopsy Testing Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Breast Cancer Liquid Biopsy Testing Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Breast Cancer Liquid Biopsy Testing Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Breast Cancer Liquid Biopsy Testing Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Breast Cancer Liquid Biopsy Testing Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Breast Cancer Liquid Biopsy Testing Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Breast Cancer Liquid Biopsy Testing Devices in Asia Pacific. In particular, China, India, and South East Asian Breast Cancer Liquid Biopsy Testing Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Breast Cancer Liquid Biopsy Testing Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Breast Cancer Liquid Biopsy Testing Devices.
Breast Cancer Liquid Biopsy Testing Devices Market Company Profiles
The global Breast Cancer Liquid Biopsy Testing Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are A. Menarini Industrie Farmaceutiche Riunite Srl, Agena Bioscience Inc, Bio Rad Laboratories Inc, Exact Sciences Corp, F. Hoffmann La Roche Ltd, Fluxion Biosciences Inc, Guardant Health Inc, Illumina Inc, Isogen Life Science BV, Myriad Genetics Inc, Natera Inc, NeoGenomics Laboratories Inc, Novogene Corp, OncoDNA SA, Pfizer Inc, QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp, Thermo Fisher Scientific Inc.
Recent Breast Cancer Liquid Biopsy Testing Devices Market Developments
The global Breast Cancer Liquid Biopsy Testing Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Breast Cancer Liquid Biopsy Testing Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
A. Menarini Industrie Farmaceutiche Riunite Srl
Agena Bioscience Inc
Bio Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann La Roche Ltd
Fluxion Biosciences Inc
Guardant Health Inc
Illumina Inc
Isogen Life Science BV
Myriad Genetics Inc
Natera Inc
NeoGenomics Laboratories Inc
Novogene Corp
OncoDNA SA
Pfizer Inc
QIAGEN NV
SAGA Diagnostics AB
Sysmex Corp
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Breast Cancer Liquid Biopsy Testing Devices Market Overview and Key Findings, 2024
1.2 Breast Cancer Liquid Biopsy Testing Devices Market Size and Growth Outlook, 2021- 2030
1.3 Breast Cancer Liquid Biopsy Testing Devices Market Growth Opportunities to 2030
1.4 Key Breast Cancer Liquid Biopsy Testing Devices Market Trends and Challenges
1.4.1 Breast Cancer Liquid Biopsy Testing Devices Market Drivers and Trends
1.4.2 Breast Cancer Liquid Biopsy Testing Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Breast Cancer Liquid Biopsy Testing Devices Companies
2. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Breast Cancer Liquid Biopsy Testing Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.2 Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.5 Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.8 North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.11 South America Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.14 Middle East Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
7. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BREAST CANCER LIQUID BIOPSY TESTING DEVICES COMPANY PROFILES
8.1 Profiles of Leading Breast Cancer Liquid Biopsy Testing Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
A. Menarini Industrie Farmaceutiche Riunite Srl
Agena Bioscience Inc
Bio Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann La Roche Ltd
Fluxion Biosciences Inc
Guardant Health Inc
Illumina Inc
Isogen Life Science BV
Myriad Genetics Inc
Natera Inc
NeoGenomics Laboratories Inc
Novogene Corp
OncoDNA SA
Pfizer Inc
QIAGEN NV
SAGA Diagnostics AB
Sysmex Corp
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Breast Cancer Liquid Biopsy Testing Devices Market Overview and Key Findings, 2024
1.2 Breast Cancer Liquid Biopsy Testing Devices Market Size and Growth Outlook, 2021- 2030
1.3 Breast Cancer Liquid Biopsy Testing Devices Market Growth Opportunities to 2030
1.4 Key Breast Cancer Liquid Biopsy Testing Devices Market Trends and Challenges
1.4.1 Breast Cancer Liquid Biopsy Testing Devices Market Drivers and Trends
1.4.2 Breast Cancer Liquid Biopsy Testing Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Breast Cancer Liquid Biopsy Testing Devices Companies
2. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Breast Cancer Liquid Biopsy Testing Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.2 Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.5 Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.8 North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.11 South America Pacific Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Breast Cancer Liquid Biopsy Testing Devices Market, 2025
5.14 Middle East Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Breast Cancer Liquid Biopsy Testing Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Breast Cancer Liquid Biopsy Testing Devices Industry Drivers and Opportunities
7. BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BREAST CANCER LIQUID BIOPSY TESTING DEVICES COMPANY PROFILES
8.1 Profiles of Leading Breast Cancer Liquid Biopsy Testing Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
A. Menarini Industrie Farmaceutiche Riunite Srl
Agena Bioscience Inc
Bio Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann La Roche Ltd
Fluxion Biosciences Inc
Guardant Health Inc
Illumina Inc
Isogen Life Science BV
Myriad Genetics Inc
Natera Inc
NeoGenomics Laboratories Inc
Novogene Corp
OncoDNA SA
Pfizer Inc
QIAGEN NV
SAGA Diagnostics AB
Sysmex Corp
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
